Last updated: 2026-09-29 16:12:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Microbot Medical, Inc. (MBOT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $1,26, with a market capitalization of $83,96M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,24 to $3,46. This page covers its latest market performance, valuation, price trends and company information.
$83,96M | |
$1,27 | |
$192,03 | |
$0,82 | |
$1,25 | |
274,53K | |
620,25K | |
-- | |
$3,46 | |
$1,24 | |
-- | |
-- |
Microbot Medical, Inc. (MBOT) is currently trading at $1,26 as of 2026-09-29 16:11:00, up 0,40% ($0,00) from the previous close of $1,25
During today's regular trading session, MBOT has traded between $0,82 and $192,03, with a trading volume of 274,53K shares. The current price is near the lower end of today's range.
Over the past seven days, Microbot Medical, Inc. (MBOT) moved from $1,35 to $1,26, representing a decline of 7,04% ($0,10).
The stock traded between $1,24 and $1,39 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 515,04 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0,7%
MBOT is currently trading at $1,26, placing it 0,7% of the way from its 52-week low of $1,24 to its 52-week high of $3,46. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 22 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Microbot Medical, Inc. (MBOT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.